Curriculum · Gynecology / Women's Health / Infertility / Perinatal Care / Birth Spacing
Hyperthyroidism in pregnancy
Why it is treated at all
Overt hyperthyroidism during pregnancy is associated with adverse effects to the mother and fetus, so treatment is required.
The question is therefore not whether to treat but with what. The two antithyroid medications carry different risks, and which one is preferred changes with the trimester.
The drug of choice by trimester
- First trimester: propylthiouracil is preferred, since methimazole is associated with birth defects when used in the first trimester
- After the first trimester: methimazole should be considered, because the risk of congenital anomalies is less than the risk of liver failure associated with propylthiouracil
So neither drug is preferred at every point of the pregnancy. The reason the choice changes is that the two risks are not equal at the same time: birth defects with methimazole early, liver failure with propylthiouracil later.
Radioactive iodine, which is the answer to avoid
Radioactive iodine would not be appropriate during pregnancy. Surgery and radioactive iodine should only be used if there is a clear indication.
The surgery file gives it as a preparation rule for iodine ablation therapy: it is contraindicated in pregnancy, and ladies should avoid pregnancy for 6-12 months. Women at reproductive age between 25-40 are less favoured to go for ablation at all, and the best candidates are graves disease patients.
The rest of that preparation shows how far ablation is from a pregnancy: thyroxine is stopped 4 weeks before, seafood and iodized salt are not eaten 2 weeks before, and the patient is kept in an isolation room for 5 days and then not allowed to leave her room at home for 5 days, a total of 10 days of isolation.